.png)
In 2023 as many as 11 biosimilars to Humira are headed for the US market.
Tony Hagen
Advertisement
Articles by Tony Hagen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
3
Auricular Acupuncture for Facial Rejuvenation: Results from a Large Real-World Clinical Series
4
Off-Label Case Series: Topical Roflumilast for Mild HS
5